|
The Pharmaceutical
Journal Vol 267 No 7162 p259 |
Products |
Recall Hydralazine 25mg tablets |
Prescription ProductsXefo tablets and injectionComposition: Tablets, lornoxicam 4mg and 8mg; injection (reconstituted) 8mg/2ml. Presentation: Film-coated tablets; powder for injection. Class: Non-steroidal anti-inflammatory drug of the oxicam family. Indications: Tablets and injection, treatment of moderate postoperative pain such as pain after dental surgery and treatment of pain associated with acute lumbo-sciatica. Lornoxicam tablets are also indicated for symptomatic treatment of pain and inflammation in osteoarthritis and rheumatoid arthritis. Major cautions: Both lornoxicam tablets and injection must not be administered to patients under 18 years of age. Lornoxicam injection must not be given to those aged 65 years and over. Contact details: CeNeS Pharmaceuticals, Compass House, Chivers Way, Histon, Cambridge CB4 9ZR. For medical enquiries, tel 0870 241 3674; for supplies (care of Healthcare Logistics), tel 01753 658339, fax 01753 658319. Legal category: POM. Net price: Tablets 4mg 30 £8.85 8mg 30 £8.85; injection 1 vial £2.25. To be launched in September. See SPC for further details. |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal